Protein & Cell >

2023 , Vol. 14 >Issue 5: 387 - 392

DOI: https://doi.org/10.1093/procel/pwac039

LETTER

Mechanism and design of allosteric activators of SIRT1

  • Fei Liu 1 ,
  • Ningning Pang 1 ,
  • Rui-Ming Xu 2 ,
  • Na Yang , 1
Expand
  • 1. State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Key Laboratory of Medical Data Analysis and Statistical Research of Tianjin, Nankai University, Tianjin 300353, China
  • 2. National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
yangnanku@nankai.edu.cn

Accepted date: 01 Jul 2022

Published date: 15 May 2023

Copyright

2022 The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.
Fold

Cite this article

Fei Liu , Ningning Pang , Rui-Ming Xu , Na Yang . Mechanism and design of allosteric activators of SIRT1[J]. Protein & Cell, 2023 , 14(5) : 387 -392 . DOI: 10.1093/procel/pwac039

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005;280:17187–95.

DOI

2
Cao D, Wang M, Qiu X et al. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol. Genes Dev 2015;29:1316–25.

DOI

3
Dai H, Case AW, Riera TV et al. Crystallographic structure of a small molecule SIRT1 activator-enzyme complex. Nat Commun 2015;6:7645.

DOI

4
Dai H, Kustigian L, Carney D et al. SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem 2010;285:32695–703.

DOI

5
Guarente L. Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 2011;364:2235–44.

DOI

6
Howitz KT, Bitterman KJ, Cohen HY et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191–6.

DOI

7
Hsu HC, Wang CL, Wang M et al. Structural basis for allosteric stimulation of Sir2 activity by Sir4 binding. Genes Dev 2013;27:64–73.

DOI

8
Hubbard BP, Gomes AP, Dai H et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 2013;339:1216–9.

DOI

9
Liu F, Yang N. Multiscale landscape of molecular mechanism of SIRT1 activation by STACs. Phys Chem Chem Phys 2020;22:826–37.

DOI

10
Lu Q, Wang J. Single molecule conformational dynamics of adenylate kinase: energy landscape, structural correlations, and transition state ensembles. J Am Chem Soc 2008;130:4772–83.

DOI

11
Milne JC, Denu JM. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 2008;12:11–7.

DOI

12
Milne JC, Lambert PD, Schenk S et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007;450:712–6.

DOI

13
Pacholec M, Bleasdale JE, Chrunyk B et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010;285:8340–51.

DOI

14
Whitford PC, Miyashita O, Levy Y et al. Conformational transitions of adenylate kinase: switching by cracking. J Mol Biol 2007;366:1661–71.

DOI

15
Wu J, Zhang D, Chen L et al. Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate. J Med Chem 2013;56:761–80.

DOI

Options
Outlines

/

〈 〉